Future studies are necessary to evaluate if the reintroduction of LHPP can also prevent or rescue colitis, and whether targeting histidine phosphorylation could be a path forward to develop novel therapeutics in the field of IBD and/or CRC. Here, LHPP is linked to inflammatory bowel disease.